HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pan Wang Selected Research

Nasopharyngeal Carcinoma

12/2023Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
11/2023Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
11/2023Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trial.
1/2023A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients.
1/2023Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
10/2022Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
12/2021Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.
12/2021Induction or adjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in paediatric nasopharyngeal carcinoma in the IMRT era: A recursive partitioning risk stratification analysis based on EBV DNA.
11/2018Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study.
1/2018Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pan Wang Research Topics

Disease

178Neoplasms (Cancer)
04/2024 - 12/2006
38Breast Neoplasms (Breast Cancer)
04/2024 - 11/2008
27Inflammation (Inflammations)
04/2024 - 03/2012
20Hepatocellular Carcinoma (Hepatoma)
01/2024 - 01/2008
19Neoplasm Metastasis (Metastasis)
01/2023 - 12/2011
16Infections
02/2024 - 01/2017
16Glioma (Gliomas)
06/2023 - 03/2015
15Leukemia
06/2019 - 08/2012
14Alzheimer Disease (Alzheimer's Disease)
02/2024 - 02/2014
13Sarcoma 180
12/2015 - 12/2006
12Hypoxia (Hypoxemia)
03/2022 - 02/2014
10Nasopharyngeal Carcinoma
12/2023 - 01/2018
10Stomach Neoplasms (Stomach Cancer)
08/2023 - 01/2019
10Wounds and Injuries (Trauma)
07/2023 - 01/2019
10Body Weight (Weight, Body)
05/2023 - 07/2017
9Carcinoma (Carcinomatosis)
12/2023 - 01/2009
8Pain (Aches)
11/2023 - 01/2015
8Neurodegenerative Diseases (Neurodegenerative Disease)
05/2023 - 10/2016
8Non-alcoholic Fatty Liver Disease
02/2023 - 01/2018
8Carcinogenesis
01/2023 - 09/2016
7Obesity
05/2022 - 01/2013
7Esophageal Neoplasms (Esophageal Cancer)
02/2020 - 01/2014
7Colorectal Neoplasms (Colorectal Cancer)
06/2019 - 01/2014
6Parkinson Disease (Parkinson's Disease)
04/2024 - 12/2015
6Cognitive Dysfunction
04/2024 - 01/2018
6Insulin Resistance
01/2024 - 01/2020
6Ovarian Neoplasms (Ovarian Cancer)
01/2024 - 10/2015
6Necrosis
05/2023 - 06/2013
6Brain Neoplasms (Brain Tumor)
01/2023 - 03/2017
5Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 12/2015
5Mitochondrial Diseases (Mitochondrial Disease)
08/2023 - 01/2017
5COVID-19
01/2023 - 01/2021
5Glioblastoma (Glioblastoma Multiforme)
01/2023 - 03/2017
5Asthma (Bronchial Asthma)
09/2022 - 04/2018
5Ascites
01/2022 - 01/2009
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 10/2017
5Lung Neoplasms (Lung Cancer)
04/2021 - 01/2017
5Osteoporosis
02/2021 - 01/2015
5Neuroblastoma
01/2021 - 08/2013
5Esophageal Squamous Cell Carcinoma
01/2019 - 03/2012
4Melanoma (Melanoma, Malignant)
04/2023 - 01/2020
4Hyperlipidemias (Hyperlipidemia)
11/2022 - 02/2020
4Colonic Neoplasms (Colon Cancer)
01/2022 - 04/2012
4Thrombosis (Thrombus)
01/2022 - 12/2015
4Adenocarcinoma of Lung
06/2021 - 07/2014

Drug/Important Bio-Agent (IBA)

43Proteins (Proteins, Gene)FDA Link
04/2024 - 07/2008
24Biomarkers (Surrogate Marker)IBA
04/2024 - 07/2016
211-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2021 - 06/2012
21protoporphyrin IXIBA
04/2016 - 12/2006
17LipidsIBA
04/2024 - 03/2008
14EnzymesIBA
04/2024 - 01/2008
12MicroRNAs (MicroRNA)IBA
02/2024 - 01/2014
11sinoporphyrin sodiumIBA
08/2022 - 01/2014
10DNA (Deoxyribonucleic Acid)IBA
11/2023 - 04/2010
9LigandsIBA
01/2024 - 11/2008
9Cisplatin (Platino)FDA LinkGeneric
12/2023 - 01/2018
9Reactive Oxygen Species (Oxygen Radicals)IBA
04/2023 - 06/2009
9HematoporphyrinsIBA
02/2010 - 10/2007
8Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2024 - 10/2021
8Messenger RNA (mRNA)IBA
05/2023 - 03/2012
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 03/2015
7CytokinesIBA
01/2024 - 01/2018
7Eosine Yellowish-(YS) (Eosin)IBA
11/2023 - 01/2015
7Hematoxylin (Haematoxylon)IBA
11/2023 - 01/2015
7Liposomes (Liposome)IBA
11/2023 - 10/2017
7ResveratrolIBA
12/2022 - 01/2020
7Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 12/2014
7tri-o-cresyl phosphate (TOCP)IBA
01/2021 - 08/2013
7phytochlorinIBA
12/2016 - 11/2013
6Therapeutic UsesIBA
02/2024 - 07/2016
6AntioxidantsIBA
01/2024 - 01/2008
6RNA (Ribonucleic Acid)IBA
01/2024 - 01/2014
6Paclitaxel (Taxol)FDA LinkGeneric
11/2023 - 11/2013
6Glucose (Dextrose)FDA LinkGeneric
08/2023 - 10/2017
6Oxygen (Dioxygen)IBA
05/2021 - 04/2008
6Small Interfering RNA (siRNA)IBA
01/2020 - 09/2014
5MelatoninIBA
03/2023 - 01/2016
5PolyphenolsIBA
01/2023 - 01/2020
5AntigensIBA
01/2023 - 10/2019
5CateninsIBA
09/2022 - 01/2018
5Photosensitizing Agents (Photosensitizers)IBA
05/2021 - 03/2016
4Amyloid (Amyloid Fibrils)IBA
08/2023 - 02/2014
4HydrogelsIBA
07/2023 - 12/2011
4VaccinesIBA
05/2023 - 05/2022
4CholesterolIBA
04/2023 - 01/2019
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 11/2014
4CalciumIBA
01/2023 - 01/2013
4LipopolysaccharidesIBA
07/2022 - 12/2015
4Triglycerides (Triacylglycerol)IBA
02/2022 - 12/2017
4Long Noncoding RNAIBA
01/2022 - 10/2016

Therapy/Procedure

91Therapeutics
12/2023 - 01/2007
25Drug Therapy (Chemotherapy)
01/2023 - 01/2011
21Photochemotherapy (Photodynamic Therapy)
05/2021 - 06/2012
11Precision Medicine
01/2024 - 01/2015
9Chemoradiotherapy
12/2023 - 01/2018
9Lasers (Laser)
01/2023 - 05/2013
8Radiotherapy
11/2023 - 04/2017
4Immunotherapy
12/2023 - 03/2018
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2023 - 01/2018
4Ultrasonic Therapy
09/2021 - 02/2009